- Home
- NXTC vs MI Comparison
NXTC vs MI Comparison
Compare NXTC & MI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- MI
- Stock Information
- Founded
- NXTC 2015
- MI 2009
- Country
- NXTC United States
- MI Hong Kong
- Employees
- NXTC N/A
- MI N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- MI Catalog/Specialty Distribution
- Sector
- NXTC Health Care
- MI Consumer Discretionary
- Exchange
- NXTC Nasdaq
- MI Nasdaq
- Market Cap
- NXTC 40.3M
- MI 38.8M
- IPO Year
- NXTC 2019
- MI N/A
- Fundamental
- Price
- NXTC $1.31
- MI $3.38
- Analyst Decision
- NXTC Strong Buy
- MI
- Analyst Count
- NXTC 2
- MI 0
- Target Price
- NXTC $4.00
- MI N/A
- AVG Volume (30 Days)
- NXTC 44.0K
- MI 58.5K
- Earning Date
- NXTC 11-07-2024
- MI 01-01-0001
- Dividend Yield
- NXTC N/A
- MI N/A
- EPS Growth
- NXTC N/A
- MI N/A
- EPS
- NXTC N/A
- MI 1.16
- Revenue
- NXTC N/A
- MI $1,273,946.00
- Revenue This Year
- NXTC N/A
- MI N/A
- Revenue Next Year
- NXTC N/A
- MI N/A
- P/E Ratio
- NXTC N/A
- MI $2.89
- Revenue Growth
- NXTC N/A
- MI N/A
- 52 Week Low
- NXTC $1.03
- MI $3.08
- 52 Week High
- NXTC $2.57
- MI $16.70
- Technical
- Relative Strength Index (RSI)
- NXTC 45.61
- MI 27.09
- Support Level
- NXTC $1.30
- MI $8.28
- Resistance Level
- NXTC $1.60
- MI $10.29
- Average True Range (ATR)
- NXTC 0.08
- MI 1.19
- MACD
- NXTC 0.00
- MI -0.36
- Stochastic Oscillator
- NXTC 12.12
- MI 4.03
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease.
About MI NFT Limited
NFT Ltd Formerly Takung Art Co Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.